Executive Summary On August 28, 2015, the Health Resources and Services Administration (“HRSA”) released its long-awaited proposed 340B Drug Pricing Program Omnibus Guidance. The notice (a copy of which can be found here) proposes to establish guidance addressing a variety of longstanding open questions for covered entities enrolled in, and drug manufacturers participating in, the…Read More
340B Program Omnibus Guidance: A Deeper Dive
Posted on September 3, 2015 in Health Law News
Published by: Hall Render